Hibicke, M.
Nichols, C. D.
Funding for this research was provided by:
National Institutes of Health (R21DA039462)
Eleusis Therapeutics
Article History
Received: 3 March 2022
Accepted: 26 April 2022
First Online: 15 June 2022
Competing interests
: M.H. has no competing interests. C.D. Nichols is a member of the Scientific Advisory Board of Eleusis Therapeutics, and has a Sponsored Research Contract with Eleusis Therapeutics.